Recently, Jiangsu Sanmi Technology Co., Ltd. (hereinafter referred to as “Sanmi Biology”) announced the completion of the Pre-A round of financing of tens of millions of yuan. This round of financing was led by Nantong Investment Management, focusing on biotechnology innovation The Zhigeng Fund, which was incubated by investment, followed up with investment and blessing. The funds raised will be used to research and develop new bio-based materials, build a mass spectrometry multi-omics and starch polysaccharide research and development platform, accelerate the development and implementation of innovative application scenarios for bio-based new materials, and build a production layout for the entire industry chain. At the same time, in August 2022, Sanmi Biology has obtained an exclusive investment of tens of millions of yuan in the angel round from Zhigeng Fund, and the funds raised will be used to promote the research and development of Sanmi Biological products and customer verification.
From seeds to new materials, Sanmi Biology has comprehensively deployed the bio-based new material track
Founded in 2014, Sanmi Biotech has established an internationally leading research and testing service platform that integrates mass spectrometry multi-omics, starch polysaccharide analysis and plant-based new material R&D and production. It is committed to providing professional scientific research and technical services, covering medicine, plants science, agronomy, traditional Chinese medicinal materials, environment, soil, plant-based new materials, etc.; can provide functional polysaccharide analysis, starch structure analysis, high-throughput sequencing, proteomics and metabolomics services, and has provided nearly 5,000 universities , scientific research institutes and enterprises to provide high-quality technical services.
Sanmi Biological R&D Center
Relying on continuous R&D accumulation and technological innovation, Sanmi Bio has comprehensively deployed the plant-based new material track, and has established a full industrial chain operation model from gene editing, new variety selection, cell factories to the launch of plant-based new material products, forming Sanmi Bio own business ecosystem. The products cover new polymer flame retardant polyethylene materials, new special functional starches, plant-based degradable materials, plant-based adhesives, plant-based capsules and other directions; the company has passed ISO9001 quality management system certification and ISO14001 environmental management system certification during the same period , ISO45001 occupational health and safety management certification and CNAS certification, and has many honorary qualifications such as national small and medium-sized technology-based small and medium-sized enterprises, high-tech enterprises in Jiangsu Province, and private technology enterprises in Jiangsu Province.
Core technology empowers industry
Zhou Wenzhi, CEO of Sanmi Biology:
Sanmi Biology has built a detection and industrialization platform around starch polysaccharides, and has now moved towards multi-variety starch synthesis pathways, realizing the directional cultivation of special starches. Starch-based materials, as an important part of bio-based new materials, have important social significance for the development of circular economy under the background of double carbon. Nantong Investment Management recognizes the company team and the prospect of industrialization of plant-based new materials, and moves forward with Sanmi Biology, adheres to new development concepts, unswervingly follows the path of ecological priority, green development, and jointly builds a clean and beautiful world.
About Nantong Investment Management
Nantong Investment Management Co., Ltd. was established in September 2005 with a registered capital of RMB 500 million. It is the earliest company engaged in private equity investment in the state-owned assets system of Nantong. Its wholly-owned subsidiaries Nantong Technology Venture Capital Management Co., Ltd. and Nantong Bauhinia Capital Management Co., Ltd. has obtained the registration qualification of private equity fund managers. The company’s business includes the management of funds of funds and direct investment funds. Up to now, the company’s parent fund has a total of 64 cooperative fund managers, with a total scale of 48 billion; direct investment funds are under management with a scale of 2.5 billion, and a total of 64 companies have invested.
微信扫一扫打赏
Chinese